New in the Library (July – August 2025)
Here are the latest items added to the CTN Dissemination Library for July – August 2025 (this post will be updated as new items come in):
Exploring Clinical Profile and Treatment Outcome Differences Based on Baseline Smoking and Alcohol Co-Use Status Among Individuals Initiating Medication for Opioid Use Disorder Treatment. León G, et al. American Journal on Addictions 2025 (in press). (CTN-0027)
Understanding the Characteristics and Comorbidities of Primary Care Patients with Risky Opioid Use: Baseline Data from the Multi-Site “Subthreshold Opioid Use Disorder Prevention” (STOP) Trial. Rostam-Abadi Y, et al. Journal of General Internal Medicine 2025 (in press). (CTN-0101)
Suicidal Ideation in Adults with Opioid Use Disorder Treated with Buprenorphine-Naloxone versus Extended-Release Naltrexone. Rizk R, et al. American Journal of Drug and Alcohol Abuse 2025 (in press). (CTN-0051)
Clinical Decision Support System for Primary Care of Opioid Use Disorder: A Randomized Clinical Trial. Rossom RC, et al. JAMA Internal Medicine 2025 (in press). (primary outcomes for CTN-0095)
Why is Substance Use Missing from My Patient’s Problem List? CTN Research to Advance Screening, Prevention, and Treatment of Substance Use in Primary Care [commentary]. McNeely J, et al. Journal of Substance Use & Addiction Treatment 2025;209780 (in press).
Research Agenda Evaluating Measurement-Based Care for Opioid Use Disorder Among Patients with Co-Occurring Depressive Disorders [opinion]. Ghitza UE. Frontiers in Psychiatry 2025;16:1624642.
Early Change in Depressive Symptom Severity with Naltrexone-Bupropion Combination and its Association with Reduction in Methamphetamine Use in ADAPT-2 Trial. Jha MK, et al. Journal of Clinical Psychiatry 2025;86(3):25m15825. (CTN-0068)
Personally-Tailored Opioid-Overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) Significantly Increases MOUD and Overdose Knowledge in Peripartum Individuals: Results from a Randomized Controlled Pilot Trial. Winhusen TJ et al. Drug and Alcohol Dependence 2025;275:112795. (Primary outcomes for CTN-0150)